The end of a 35-year bond bull market, the rise of so-called robojobs, rapid developments in gene editing and the 'sharing economy' will be among the themes that will interest investors next year and beyond, according to Investec Wealth & Investment's...
US govt likely to be supportive of biomedical research
As the most exciting US Presidential race in decades reaches its conclusion, three fund managers from Pioneer Investments give their views on the implications for different asset classes.
Subject to shareholder approval
Latest roundup by QuotedData
Chris Smith, analyst - Japanese equities at Polar Capital, discusses the evolution of the Japanese market and the search for income.
Overuse of antibiotics around the globe has created a worrying increase in resistance to many commonly used drugs, writes Carl Harald Janson, lead manager on the International Biotechnology trust.
With all three rating agencies lowering growth expectations for the domestic economy following the referendum result last month, the attractions of investing for long-term growth in the technology related sectors has again been highlighted in our view....